Pricing Log in Create free account

Enveric Biosciences, Inc. (ENVB) vs FibroBiologics Inc. (FBLG)

Enveric Biosciences, Inc. and FibroBiologics Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and FibroBiologics Inc. are of similar size ($6.4M and $6.3M). Across the 9 metrics below, Enveric Biosciences, Inc. leads on 6 and FibroBiologics Inc. on 3.

Valuation

Metric ENVB FBLG Biotechnology median
P/E n/m n/m 10.60
P/S 0.16 n/m 9.40
P/B 0.70 1.31 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.27 n/m 0.66
EV/Sales (0.07) n/m 9.02
Earnings yield (1,322.27%) (584.21%) (32.88%)
Free cash flow yield (188.36%) (247.37%) (23.13%)

Profitability

Metric ENVB FBLG Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (235.48%) (660.08%) (51.96%)
Return on assets (193.53%) (166.14%) (46.06%)
Return on invested capital 0.00% (932.71%) 0.00%

Growth

Metric ENVB FBLG Biotechnology median
Revenue growth (TTM) (13.93%) — 6.76%
EPS growth (last fiscal year) 84.14% (23.53%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ENVB FBLG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.21 2.64 4.97
Net debt to EBITDA 0.55 0.31 1.01

Dividend

Metric ENVB FBLG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENVB FBLG Biotechnology median
Market cap 6.26m 6.37m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack